Cutaneous lymphoproliferative disorders research

Cutaneous lymphoproliferative disorders are a heterogeneous group of lymphoid malignancies that arise primarily in the skin, with mycosis fungoides and Sézary syndrome representing the most common subtypes of cutaneous T-cell lymphoma. Because these conditions range from indolent, patch-stage disease to aggressive systemic illness, accurate classification — anchored by frameworks such as the WHO-EORTC system — and reliable prognostic markers are essential for guiding treatment decisions and predicting survival. Current research is working to clarify the molecular and genomic drivers of disease progression, including how CD30 expression and T-cell clonality relate to clinical outcomes, while also evaluating the long-term efficacy and tolerability of targeted therapies such as bexarotene and denileukin diftitox. A central open question remains why some patients follow an indolent course for decades while others transform rapidly, and resolving that question will likely require integrating genomic profiling with clinical staging in ways the field has not yet fully standardized.

Works

42,822

Total citations

434,982

Keywords

Cutaneous LymphomasMycosis FungoidesSézary SyndromeEORTC ClassificationT-Cell LymphomaCD30+ Lymphoproliferative Disorders